00000nam 2200000zi 4500 9.913162 CaOODSP 20221101090033 m o d f cr mn||||||||| 220708e202209 onca ob f000 0 eng d 9780660444864 CaOODSP eng rda CaOODSP n-cn--- HP5-140/2022E-PDF Supplemental statement - recombinant influenza vaccines : Canadian immunization guide chapter on influenza and statement on seasonal influenza vaccine for 2022-2023. Supplemental statement - quadrivalent recombinant influenza vaccines [Ottawa] : Public Health Agency of Canada = Agence de la santé publique du Canada, September 2022. ©2022 1 online resource (57 pages) : illustration text txt rdacontent computer c rdamedia online resource cr rdacarrier Issued also in French under title: Déclaration supplémentaire - vaccins antigrippaux recombinants : chapitre sur la grippe du guide canadien d'immunisation et déclaration sur la vaccination antigrippale pour la saison 2022-2023. Cover title. On cover: An advisory committee statement (ACS), National Advisory Committee on Immunization (NACI). "Pub.: 220317." Issued also in HTML format. Includes bibliographical references (pages 51-54). Influenza vaccines Canada. Influenza vaccines Government policy Canada. Public Health Agency of Canada, issuing body. Canada. National Advisory Committee on Immunization, issuing body. Déclaration supplémentaire - vaccins antigrippaux recombinants : (CaOODSP)9.913163 PDF 929 KB https://publications.gc.ca/collections/collection_2022/aspc-phac/HP5-140-2022-eng.pdf HTML N/A https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/recombinant-influenza-vaccines-supplemental-statement-canadian-immunization-guide-seasonal-influenza-vaccine-2022-2023.html 220317